July 6, 2017
Celgene and BeiGene join to fight cancer
Celgene Corporation and BeiGene have entered into a strategic collaboration to develop and commercialize BeiGene’s investigational anti-programmed cell death protein 1…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
July 6, 2017
Novartis updates label for psoriasis drug in EU
The Committee for Medicinal Products for Human Use (CHMP) has approved a label update for Novartis’s Cosentyx (secukinumab), the first interleukin-17A (IL-17A) approved to treat psoriasis.
July 5, 2017
Stada makes big board changes
STADA Arzneimittel AG has appointed Engelbert Coster Tjeenk Willink as Chief Executive Officer with immediate effect.
July 4, 2017
First patients get NOX-A12 combined with Keytruda in certain cancers
NOXXON Pharma, a biotechnology company whose core focus is on improving cancer treatment by targeting the tumor microenvironment, has treated first patients in its Phase 1/2 clinical trial in patients with metastatic colorectal and pancreatic cancer at the National Center for Tumor Diseases in Heidelberg, Germany.
July 3, 2017
Ipsen’s third phase trial of Somatuline lead to Japan’s clearance for new indication, certain tumors
Ipsen’s partner Teijin Group healtcare’s Pharma Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for Ipsen’s subcutaneous drug Somatuline (lanreotide) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP NET).
July 3, 2017
AstraZeneca completes two commercial rights deals, payments included in Q2 2017
AstraZeneca on Monday reported closing two different agreements for certain commercial rights for its drugs, in Europe and worldwide.
June 29, 2017
Map of malaria funding in Africa uneven despite death risks – study
About a quarter of countries in sub-Saharan Africa receive little funding for research into malaria despite having high death rates, according to a study on Thursday that highlighted the unequal spread of resources to tackle the disease.
June 23, 2017
LEADER trial data included in Novo Nordisks Saxenda in Europe
Novo Nordisk got the right from the European Medicines Agency’s committee (EMA) to include data from the LEADER trial to Saxenda to the results from the trial showed the long-term effects of Victoza for type 2 diabetes and established cardiovascular disease patients.
June 21, 2017
Drugmaker Mylan gets boost from unlikely source: coal
Mylan N.V. <MYL.O> is best known for producing EpiPen emergency allergy treatments and generic drugs.
June 21, 2017
U.S. Supreme Court ruling threatens masive talc litigation against J&J
Johnson & Johnson is seizing upon a U.S. Supreme Court ruling from Monday limiting where injury lawsuits can be filed to fight off claims it failed to warn women that talcum powder could cause ovarian cancer.